AI study on frailty risk in adult congenital heart disease
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial uses artificial intelligence to predict frailty risk in adults with congenital heart disease. It aims to identify those at higher risk so earlier support can be given.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years old or older.
- You have been diagnosed with congenital heart disease by a doctor.
- You can communicate in Mandarin or Taiwanese and have normal thinking ability.
- You do not have other birth defects or major health problems from birth.
- You are not currently in the hospital for sudden worsening of your condition.
- You do not have severe memory or thinking problems, or mental health symptoms that make it hard to answer questions.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to help evaluate heart ultrasounds. It is testing whether AI can accurately measure heart function in adults with various heart conditions, such as coronary disease, valve problems, high blood pressure, atrial fibrillation, heart failure, or cardiomyopathy.
This study uses artificial intelligence to analyze heart ultrasounds from people hospitalized with heart failure. It aims to see if AI can help doctors better measure heart function and guide treatment.
This study uses artificial intelligence (AI) to look at heart signals (electrocardiography or ECG) and ultrasound images of the heart to check for heart disease. It aims to better understand heart health in different groups of people.
This study uses artificial intelligence (AI) to look at your heart tests (ECG and echo) and find people who might have a specific heart muscle disease called ATTR-CM. The goal is to catch it earlier so treatment can start sooner.
This study uses artificial intelligence to analyze heart ultrasound images from patients hospitalized with serious heart conditions. It aims to improve how doctors predict patient outcomes.
This study uses an AI tool to look at your ECG (a simple heart test) to help find early signs of atrial fibrillation (an irregular heartbeat) or structural heart disease (changes in heart structure). It aims to see if the AI can help doctors catch these conditions sooner, even in people who don't yet have symptoms.
Hear when a new Adult Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.